Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis <scp>C</scp> - Concepedia

Concepedia

Publication | Closed Access

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis <scp>C</scp>

13

Citations

27

References

2014

Year

Yuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Atsushi Ono, Takashi Nakahara, Noriaki Naeshiro,

Hepatology Research

Abstract

Analysis of IFNL4 polymorphism is a valuable predictor in patients receiving TVR triple therapy.

References

	Year	Citations

Page 1